Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DRAP1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | RBM43 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | ALOX5 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | LIPI | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | QPCTL | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | SHCBP1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | SHARPIN | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | HAUS3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | CARD19 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | BRCA1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |